Gentamicin (Solution, Ointment, Drops) Instructions for Use

Instructions
Dosage forms

ATC Code

J01GB03 (Gentamicin)

Active Substance

Gentamicin (Rec.INN registered by WHO)

Clinical-Pharmacological Group

Antibiotic of the aminoglycoside group

Pharmacotherapeutic Group

Systemic antibacterial agents; aminoglycosides; other aminoglycosides

Pharmacological Action

A broad-spectrum antibiotic from the aminoglycoside group. It has a bactericidal effect. Actively penetrating the bacterial cell membrane, it irreversibly binds to the 30S subunit of bacterial ribosomes and thereby inhibits the protein synthesis of the pathogen.

It is highly active against aerobic gram-negative bacteria: Escherichia coli, Shigella spp., Salmonella spp., Enterobacter spp., Klebsiella spp., Serratia spp., Proteus spp., Pseudomonas aeruginosa, Acinetobacter spp.

It is also active against aerobic gram-positive cocci: Staphylococcus spp. (including strains resistant to penicillins and other antibiotics), some strains of Streptococcus spp.

Neisseria meningitidis, Treponema pallidum, some strains of Streptococcus spp., and anaerobic bacteria are resistant to gentamicin.

Pharmacokinetics

After intramuscular administration, it is rapidly absorbed from the injection site. C_max is reached within 30-60 minutes after intramuscular administration. Binding to plasma proteins is low (0-10%). It is distributed in the extracellular fluid and in all body tissues. It crosses the placental barrier. It is not metabolized. T_1/2 is 2-4 hours. 70-95% is excreted in the urine, a small amount in the bile.

Indications

Infectious and inflammatory diseases caused by microorganisms sensitive to gentamicin: infections of the upper and lower respiratory tract (including bronchitis, pneumonia, pleural empyema), complicated urogenital infections (pyelonephritis, cystitis, urethritis, prostatitis, gonorrhea, endometritis), infections of bones and joints (including osteomyelitis), abdominal infections (peritonitis, pelvioperitonitis), CNS infections (meningitis), purulent infections of the skin and soft tissues, wound infection, burn infection.

ICD codes

Open the list of ICD codes

ICD-10 code	Indication
A54	Gonococcal infection
G00	Bacterial meningitis, not elsewhere classified
J15	Bacterial pneumonia, not elsewhere classified
J20	Acute bronchitis
J42	Unspecified chronic bronchitis
J86	Pyothorax (pleural empyema)
K65.0	Acute peritonitis (including abscess)
K81.0	Acute cholecystitis
K83.0	Cholangitis
L01	Impetigo
L02	Cutaneous abscess, furuncle and carbuncle
L03	Cellulitis
L08.0	Pyoderma
L08.8	Other specified local infections of skin and subcutaneous tissue
M00	Pyogenic arthritis
M86	Osteomyelitis
N10	Acute tubulointerstitial nephritis (acute pyelonephritis)
N11	Chronic tubulointerstitial nephritis (chronic pyelonephritis)
N30	Cystitis
N34	Urethritis and urethral syndrome
N37.0	Urethritis in diseases classified elsewhere
N41	Inflammatory diseases of prostate
N71	Inflammatory disease of uterus, excluding cervix (including endometritis, myometritis, metritis, pyometra, uterine abscess)
N72	Inflammatory disease of cervix uteri (including cervicitis, endocervicitis, exocervicitis)
N73.5	Unspecified female pelvic peritonitis
N74.3	Gonococcal inflammatory diseases of female pelvic organs
T30	Burns and corrosions of unspecified body region
T79.3	Posttraumatic wound infection, not elsewhere classified

ICD-11 code	Indication
1A7Z	Gonococcal infection, unspecified
1B70.1	Streptococcal cellulitis of the skin
1B70.2	Staphylococcal cellulitis of the skin
1B70.Z	Bacterial cellulitis or lymphangitis caused by unspecified bacterium
1B72.0	Bullous impetigo
1B72.1	Nonbullous impetigo
1B72.Z	Impetigo, unspecified
1B75.0	Furuncle
1B75.1	Carbuncle
1B75.2	Furunculosis
1B75.3	Pyogenic skin abscess
1B7Y	Other specified pyogenic bacterial infections of skin or subcutaneous tissue
1C44	Non-pyogenic bacterial infections of skin
1D01.0Z	Bacterial meningitis, unspecified
CA20.1Z	Chronic bronchitis, unspecified
CA40.0Z	Bacterial pneumonia, unspecified
CA42.Z	Acute bronchitis, unspecified
CA44	Pyothorax
DC12.0Z	Acute cholecystitis, unspecified
DC13	Cholangitis
DC50.0	Primary peritonitis
DC50.2	Peritoneal abscess
DC50.Z	Peritonitis, unspecified
EA50.3	Staphylococcal scarlet fever
EB21	Pyoderma gangrenosum
FA1Z	Infectious arthropathies, unspecified
FB84.Z	Osteomyelitis or osteitis, unspecified
GA01.Z	Inflammatory diseases of uterus, except cervix, unspecified
GA05.2	Unspecified pelvic peritonitis in women
GA91.Z	Inflammatory and other diseases of prostate, unspecified
GB50	Acute tubulo-interstitial nephritis
GB51	Acute pyelonephritis
GB55.Z	Chronic tubulo-interstitial nephritis, unspecified
GB5Z	Renal tubulo-interstitial diseases, unspecified
GC00.Z	Cystitis, unspecified
GC02.1	Nonspecific urethritis
GC02.Z	Urethritis and urethral syndrome, unspecified
NE11	Burn of unspecified body region
NF0A.3	Posttraumatic wound infection, not elsewhere classified
1A71	Gonococcal pelviperitonitis
GA05.Z	Inflammatory diseases of female pelvic organs, unspecified
GA0Z	Inflammatory diseases of female genital tract, unspecified
XA5WW1	Cervix uteri

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Solution

The dosage is set individually, taking into account the severity and location of the infection, and the sensitivity of the pathogen.

For intravenous or intramuscular administration for adults, a single dose is 1-1.7 mg/kg, the daily dose is 3-5 mg/kg; the frequency of administration is 2-4 times/day. The course of treatment is 7-10 days. Depending on the etiology of the disease, it is possible to use a dose of 120-160 mg once a day for 7-10 days or 240-280 mg as a single dose. Intravenous infusion is carried out over 1-2 hours.

For children over 2 years of age, the daily dose of gentamicin is 3-5 mg/kg; the frequency of administration is 3 times/day. For premature and newborn infants, a daily dose of 2-5 mg/kg is prescribed; the frequency of administration is 2 times/day; for children under 2 years of age, the same dose is prescribed with a frequency of administration of 3 times/day.

Patients with impaired renal excretory function require dosage adjustment depending on the creatinine clearance values.

Maximum daily doses for adults and children with intravenous or intramuscular administration are 5 mg/kg.

Drops

For topical application, Gentamicin is instilled 1-2 drops into the lower conjunctival sac of the affected eye every 1-4 hours.

Ointment

Externally – 3-4 times/day.

Adverse Reactions

From the digestive system nausea, vomiting, increased activity of hepatic transaminases, hyperbilirubinemia.

From the hematopoietic system anemia, leukopenia, granulocytopenia, thrombocytopenia.

From the urinary system oliguria, proteinuria, microhematuria, renal failure, tubular necrosis.

From the nervous system muscle twitching, paresthesia, numbness sensation, epileptic seizures, headache, drowsiness, in children – psychosis.

From the sensory organs tinnitus, hearing loss, vestibular and labyrinthine disorders, irreversible deafness.

Allergic reactions skin rash, itching, urticaria, fever; rarely – angioedema.

Other fever, development of superinfection.

Contraindications

Hypersensitivity to gentamicin and other antibiotics of the aminoglycoside group, acoustic neuritis, severe chronic renal failure with azotemia and uremia, pregnancy, lactation (breastfeeding), newborns (up to 1 month), including premature infants (due to the high risk of ototoxic and nephrotoxic effects).

With caution

Myasthenia gravis, parkinsonism, botulism (aminoglycosides can cause impairment of neuromuscular transmission, which leads to further weakening of skeletal muscles), dehydration, renal failure, old age.

Use in Pregnancy and Lactation

Gentamicin is contraindicated during pregnancy. If it is necessary to use during lactation, breastfeeding should be discontinued.

Use in Renal Impairment

Contraindicated in severe renal impairment, uremia. Use with caution in renal impairment. When using gentamicin, renal function should be monitored.

Patients with impaired renal excretory function require dosage adjustment depending on the creatinine clearance values.

In patients with chronic renal failure, the possibility of a resorptive effect of gentamicin with its external use for a long time on large skin surfaces should be considered.

Pediatric Use

Use with caution in newborns (up to 1 month), including premature infants.

Geriatric Use

In elderly patients, use should be based on renal function status.

Special Precautions

When using gentamicin, renal function, auditory and vestibular function should be monitored.

Patients with infectious and inflammatory diseases of the urinary tract should consume plenty of fluids during treatment.

Drug Interactions

It enhances the muscle relaxant effect of curare-like drugs.

It reduces the effectiveness of drugs for the treatment of myasthenia gravis.

Methoxyflurane, polymyxins for parenteral use and other drugs that block neuromuscular transmission (halogenated hydrocarbons as agents for inhalation anesthesia, narcotic analgesics, transfusion of large amounts of blood with citrate preservatives) increase the risk of nephrotoxic effects and respiratory depression (due to increased neuromuscular blockade).

With simultaneous use of gentamicin and “loop” diuretics (furosemide, ethacrynic acid), the concentration of gentamicin in the blood increases, thereby increasing the risk of toxic adverse reactions.

Toxicity is enhanced with simultaneous use with cisplatin and other oto- and nephrotoxic agents.

Penicillin antibiotics (ampicillin, carbenicillin) enhance the antimicrobial effect by expanding the spectrum of activity.

Parenteral administration of indomethacin increases the risk of toxic effects of aminoglycosides.

Pharmaceutically incompatible with other drugs.

Storage Conditions

Store at 8°C (46°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Rx Only

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Gentamicin [Belmedpreparaty RUP (Republic of Belarus)]
Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Marketing Authorization Holder

Belmedpreparaty RUP (Republic of Belarus)

Manufactured By

Belmedpreparaty RUP (Republic of Belarus)

Dosage Form

Gentamicin

Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin (as sulfate)	40 mg	80 mg

2 ml – ampoules (10) – cardboard packs.

Gentamicin [Dalkhimpharm, JSC (Russia)]
Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Marketing Authorization Holder

Dalkhimpharm, JSC (Russia)

Dosage Form

Gentamicin

Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml
Gentamicin sulfate	40 mg

1 ml – ampoules (10) – cardboard packs.

Gentamicin [Dalkhimpharm, JSC (Russia)]
Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Marketing Authorization Holder

Dalkhimpharm, JSC (Russia)

Dosage Form

Gentamicin

Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin sulfate	40 mg	80 mg

2 ml – ampoules (10) – cardboard packs.

Gentamicin [Dalkhimpharm, JSC (Russia)]
Eye drops 0.3%: bottle or dropper bottle 5 ml or 10 ml

Marketing Authorization Holder

Dalkhimpharm, JSC (Russia)

Dosage Form

Gentamicin

Eye drops 0.3%: bottle or dropper bottle 5 ml or 10 ml

Dosage Form, Packaging, and Composition

Eye drops in the form of a clear, colorless or slightly colored liquid.

	1 ml
Gentamicin	3 mg

Solution for intravenous and intramuscular administration in the form of a transparent, colorless or slightly colored liquid.

	1 ml
Gentamicin sulfate (in terms of Gentamicin base)	40 mg

Excipients: sodium disulfite (sodium metabisulfite) – 3.2 mg, disodium edetate (Trilon B) – 0.1 mg, water for injection – up to 1 ml.

2 ml – ampoules (5) – contour cell packs (1) – cardboard packs.
2 ml – ampoules (5) – contour cell packs (2) – cardboard packs.
2 ml – ampoules (10) – cardboard boxes.

Gentamicin [Microgen NPO, JSC (Russia)]
Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 5, 10 or 20 pcs.

Marketing Authorization Holder

Microgen NPO, JSC (Russia)

Dosage Form

Gentamicin

Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 5, 10 or 20 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration colorless, transparent.

	1 ml
Gentamicin (as sulfate)	40 mg

Excipients: sodium metabisulfite (sodium disulfite), sodium edetate (disodium edetate), water for injection.

1 ml – ampoules (10) – cardboard boxes.
2 ml – ampoules (10) – cardboard boxes.
1 ml – ampoules (5) – contour cell packs (1) – cardboard packs.
1 ml – ampoules (5) – contour cell packs (2) – cardboard packs.
1 ml – ampoules (10) – contour cell packs (1) – cardboard packs.
1 ml – ampoules (10) – contour cell packs (2) – cardboard packs.
2 ml – ampoules (5) – contour cell packs (1) – cardboard packs.
2 ml – ampoules (5) – contour cell packs (2) – cardboard packs.
2 ml – ampoules (10) – contour cell packs (1) – cardboard packs.
2 ml – ampoules (10) – contour cell packs (2) – cardboard packs.

Gentamicin [Microgen NPO, JSC (Russia)]
Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Marketing Authorization Holder

Microgen NPO, JSC (Russia)

Manufactured By

Virion NPO (Russia)

Dosage Form

Gentamicin

Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin (as sulfate)	40 mg	80 mg

2 ml – ampoules (10) – cardboard packs.
2 ml – ampoules (10) /with ampoule knife or scarifier if necessary/ – cardboard packs pasted with a banderole.
2 ml – ampoules (10) – cardboard packs pasted with a banderole.

Gentamicin [Promomed Rus LLC (Russia)]
Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Marketing Authorization Holder

Promomed Rus LLC (Russia)

Dosage Form

Gentamicin

Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin (as sulfate)	40 mg	80 mg

2 ml – ampoules (10) – cardboard packs.

Gentamicin [Pharmstandard-Ufimsky Vitaminny Zavod OJSC (Russia)]
Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Marketing Authorization Holder

Pharmstandard-Ufimsky Vitaminny Zavod OJSC (Russia)

Dosage Form

Gentamicin

Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml
Gentamicin (as sulfate)	40 mg

1 ml – ampoules (10) – cardboard packs.

Gentamicin [Pharmstandard-Ufimsky Vitaminny Zavod OJSC (Russia)]
Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Marketing Authorization Holder

Pharmstandard-Ufimsky Vitaminny Zavod OJSC (Russia)

Dosage Form

Gentamicin

Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin (as sulfate)	40 mg	80 mg

2 ml – ampoules (10) – cardboard packs.

Gentamicin sulfat 4% [Vifitech, CJSC (Russia)]
Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Marketing Authorization Holder

Vifitech, CJSC (Russia)

Dosage Form

Gentamicin sulfat 4%

Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin sulfate	40 mg	80 mg

2 ml – ampoules (10) – cardboard packs.
2 ml – ampoules (5) – contour cell packs (2) – cardboard packs.

Gentamicin sulfat 4% [Vifitech, CJSC (Russia)]
Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Marketing Authorization Holder

Vifitech, CJSC (Russia)

Dosage Form

Gentamicin sulfat 4%

Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml
Gentamicin sulfate	40 mg

1 ml – ampoules (10) – cardboard packs.
1 ml – ampoules (5) – contour cell packs (2) – cardboard packs.

Gentamicin sulfat 4% [Lekko, CJS (Russia)]
Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Marketing Authorization Holder

Lekko, CJS (Russia)

Dosage Form

Gentamicin sulfat 4%

Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml
Gentamicin sulfate	40 mg

1 ml – ampoules (10) – cardboard packs.
1 ml – ampoules (5) – contour cell packs (2) – cardboard packs.

Gentamicin sulfat 4% [Lekko, CJS (Russia)]
Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Marketing Authorization Holder

Lekko, CJS (Russia)

Dosage Form

Gentamicin sulfat 4%

Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin sulfate	40 mg	80 mg

2 ml – ampoules (10) – cardboard packs.
2 ml – ampoules (5) – contour cell packs (2) – cardboard packs.

Gentamicin sulfat 4% [Lens-Pharm, LLC (Russia)]
Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Marketing Authorization Holder

Lens-Pharm, LLC (Russia)

Dosage Form

Gentamicin sulfat 4%

Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml
Gentamicin sulfate	40 mg

1 ml – ampoules (10) – cardboard packs.
1 ml – ampoules (5) – contour cell packs (2) – cardboard packs.

Gentamicin sulfat 4% [Lens-Pharm, LLC (Russia)]
Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Marketing Authorization Holder

Lens-Pharm, LLC (Russia)

Dosage Form

Gentamicin sulfat 4%

Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin sulfate	40 mg	80 mg

2 ml – ampoules (10) – cardboard packs.
2 ml – ampoules (5) – contour cell packs (2) – cardboard packs.

Gentamicin sulfat 4% [Samson-Med LLC (Russia)]
Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Marketing Authorization Holder

Samson-Med LLC (Russia)

Dosage Form

Gentamicin sulfat 4%

Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml
Gentamicin sulfate	40 mg

1 ml – ampoules (10) – cardboard packs.
1 ml – ampoules (5) – contour cell packs (2) – cardboard packs.

Gentamicin sulfat 4% [Samson-Med LLC (Russia)]
Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Marketing Authorization Holder

Samson-Med LLC (Russia)

Dosage Form

Gentamicin sulfat 4%

Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin sulfate	40 mg	80 mg

2 ml – ampoules (10) – cardboard packs.
2 ml – ampoules (5) – contour cell packs (2) – cardboard packs.

Gentamicin sulfate [Mapichem AG (Switzerland)]
Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Marketing Authorization Holder

Mapichem AG (Switzerland)

Manufactured By

Shandong Weifang Pharmaceutical Factory, Co. Ltd. (China)

Dosage Form

Gentamicin sulfate

Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin sulfate	40 mg	80 mg

2 ml – ampoules (10) – plastic cell packs (1) – cardboard packs.

Gentamicin ungventum 0.1% [Bryntsalov-A, JSC (Russia)]
Ointment for external use 0.1%: tube 15 g

Marketing Authorization Holder

Bryntsalov-A, JSC (Russia)

Dosage Form

Gentamicin ungventum 0.1%

Ointment for external use 0.1%: tube 15 g

Dosage Form, Packaging, and Composition

Ointment for external use 0.1%	1 g
Gentamicin (as sulfate)	1 mg

15 g – aluminum tubes (1) – cardboard packs.

Gentamicin ungventum 0.1% [Trading House KhiMoptorg CJSC (Russia)]
Ointment for external use 0.1%: tube 15 g

Marketing Authorization Holder

Trading House KhiMoptorg CJSC (Russia)

Dosage Form

Gentamicin ungventum 0.1%

Ointment for external use 0.1%: tube 15 g

Dosage Form, Packaging, and Composition

Ointment for external use 0.1%	1 g
Gentamicin (as sulfate)	1 mg

15 g – aluminum tubes (1) – cardboard packs.

Gentamicin ungventum 0.1% [PharmNovation, LLC (Russia)]
Ointment for external use 0.1%: tube 15 g

Marketing Authorization Holder

PharmNovation, LLC (Russia)

Dosage Form

Gentamicin ungventum 0.1%

Ointment for external use 0.1%: tube 15 g

Dosage Form, Packaging, and Composition

Ointment for external use 0.1%	1 g
Gentamicin (as sulfate)	1 mg

15 g – aluminum tubes (1) – cardboard packs.

Gentamicin ungventum 0.1% [Akrikhin Chemical and Pharmaceutical Plant, JSC (Russia)]
Ointment for external use 0.1%: tube 15 g

Marketing Authorization Holder

Akrikhin Chemical and Pharmaceutical Plant, JSC (Russia)

Dosage Form

Gentamicin ungventum 0.1%

Ointment for external use 0.1%: tube 15 g

Dosage Form, Packaging, and Composition

Ointment for external use 0.1%	1 g
Gentamicin (as sulfate)	1 mg

15 g – aluminum tubes (1) – cardboard packs.

Gentamicin ungventum 0.1% [Central European Pharmaceutical Company CJS (Russia)]
Ointment for external use 0.1%: tube 15 g

Marketing Authorization Holder

Central European Pharmaceutical Company CJS (Russia)

Dosage Form

Gentamicin ungventum 0.1%

Ointment for external use 0.1%: tube 15 g

Dosage Form, Packaging, and Composition

Ointment for external use 0.1%	1 g
Gentamicin (as sulfate)	1 mg

15 g – aluminum tubes (1) – cardboard packs.

Gentamicin-AKOS [Sintez PJSC (Russia)]
Ointment for external use 0.1%: tubes 15 g

Marketing Authorization Holder

Sintez PJSC (Russia)

Dosage Form

Gentamicin-AKOS

Ointment for external use 0.1%: tubes 15 g

Dosage Form, Packaging, and Composition

Ointment for external use from white to yellow.

	100 g
Gentamicin sulfate (in terms of Gentamicin)	0.1 g

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin sulfate	40 mg	80 mg

2 ml – ampoules (5) – contour cell packs (2) – cardboard packs.

Gentamicin-K [Krka, D.D. (Slovenia)]
Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Marketing Authorization Holder

Krka, D.D. (Slovenia)

Manufactured By

Krka, D.D. (Slovenia)

Labeled By

KRKA-RUS, LLC (Russia)

Dosage Form

Gentamicin-K

Solution for intravenous and intramuscular administration 40 mg/1 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml
Gentamicin sulfate	40 mg

1 ml – ampoules (5) – contour cell packs (2) – cardboard packs.

Gentamicin-K [Krka, D.D. (Slovenia)]
Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Marketing Authorization Holder

Krka, D.D. (Slovenia)

Dosage Form

Gentamicin-K

Solution for intravenous and intramuscular administration 80 mg/2 ml: amp. 10 pcs.

Dosage Form, Packaging, and Composition

Solution for intravenous and intramuscular administration	1 ml	1 amp.
Gentamicin sulfate	40 mg	80 mg

2 ml – ampoules (10) – cardboard packs.
2 ml – ampoules (5) – contour cell packs (2) – cardboard packs.

Medixlife (Author)

View all posts Profile link